World Leprosy Day

Posted by Jesse Gehris on Jan 27, 2019 9:00:00 AM

On January 27th,  Eurofins Central Laboratory recognizes World Leprosy Day with the World Health Organization (WHO). Also known as Hansen’s disease, Leprosy is a chronic infectious disease caused by Mycobacterium Leprae. This disease affects the skin, peripheral nerves, mucus membranes of the upper respiratory tract, and eyes. Individuals affected will experience sensory loss in these affected areas as well as damaged thickened nerves.

Read More

Tags: Central Laboratory, Drug Development, Bioanalytical Testing, BioPharma, Leprosy

Moebius Syndrome Awareness Day

Posted by Jesse Gehris on Jan 24, 2019 9:00:00 AM

Today we at Eurofins Central Laboratory recognize a rare neurological disorder known as Moebius Syndrome.

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Science Education, BioPharma, Moebius Syndrome

Eurofins Central Laboratory Celebrates 30 Years of GLP

Posted by Sandra Hageman on Jan 7, 2019 9:00:00 AM

 

Celebrating Thirty Years of Good Laboratory Practice

The GLP (Good Laboratory Practice) Testing Facility of Eurofins Central Laboratory in Breda, The Netherlands has been accredited for OECD GLP for over 30 years. It all started at the BCO Centre for Research (B for Bergschot 71, the street address ever since) with the first inspection by the Dutch Health Care Inspectorate in June 1988. Over the years, BCO underwent several transformations and evolved into becoming one of the Eurofins Central Laboratory facilities, keeping the GLP Test Facility embedded in the Breda Clinical Laboratory.

Read More

Tags: Central Laboratory, Quality, Results, Bioanalytical Testing, BioPharma

Cervical Health Awareness Month

Posted by Jesse Gehris on Jan 3, 2019 2:00:00 PM

Throughout the month, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, stands with the American Cancer Society to recognize January as Cervical Cancer Awareness Month. According to the World Health Organization (WHO):

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Cervical Cancer

Antibiotic Resistance Monitoring in Ocular Microorganisms

Posted by Tracy Hendershott on Nov 26, 2018 9:00:00 AM

In the realm of infectious disease, antibiotic resistance is a real and ever increasing concern across the entire healthcare industry.  This is also true for ocular infections.  With bacterial conjunctivitis being the second most common cause (versus viral conjunctivitis), diligent epidemiology and surveillance monitoring brings valued insight to us all.  Eurofins Central Laboratory is proud to have provided analytical services (microbiological species confirmation and antibiotic resistance profile determination) to one of the only two nationwide multi-center surveillance studies (Antibiotic Resistance Monitoring in Ocular Microorganisms - ARMOR) ever undertaken in this indication. Article can be downloaded here.

Read More

Tags: Clinical Trial, Drug Development, Bioanalytical Testing

Expanding Canadian Testing Offering with Acquisition of EnvironeX

Posted by Tracy Hendershott on Nov 19, 2018 9:00:00 AM
Read More

Tags: Bioanalytical Testing, EnvironeX